Pharma-Bio Serv (OTCMKTS:PBSV) Shares Up 16.9% – Should You Buy?

Shares of Pharma-Bio Serv Inc. (OTCMKTS:PBSV) were up 16.9% during trading on Thursday . The stock traded as high as $0.5845 and last traded at $0.5845. Approximately 4,218 shares were traded during trading, an increase of 740% from the average daily volume of 502 shares. The stock had previously closed at $0.50.

Pharma-Bio Serv Stock Performance

The stock has a market capitalization of $13.39 million, a P/E ratio of -58.45 and a beta of 0.61. The company’s fifty day simple moving average is $0.50 and its two-hundred day simple moving average is $0.54.

Pharma-Bio Serv (OTCMKTS:PBSV) last issued its quarterly earnings data on Tuesday, March 17th. The company reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $1.41. Pharma-Bio Serv had a negative return on equity of 0.66% and a negative net margin of 0.86%.The company had revenue of $2.30 million during the quarter, compared to analysts’ expectations of $2.70 million. On average, research analysts predict that Pharma-Bio Serv Inc. will post 0.09 earnings per share for the current fiscal year.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.